Is Twist Bioscience Corp (TWST) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 2.6% / 30% | 8.1% / 30% | 2.0% / 30% | 3.02% / 5% | ✓ HALAL |
| DJIM | 2.6% / 33% | 8.1% / 33% | 2.0% / 33% | 3.02% / 5% | ✓ HALAL |
| MSCI | 11.8% / 33% | 36.2% / 33% | 8.9% / 33% | 3.02% / 5% | ✗ NOT HALAL |
| S&P | 2.6% / 33% | 8.1% / 33% | 2.0% / 33% | 3.02% / 5% | ✓ HALAL |
| FTSE | 11.8% / 33% | 36.2% / 33% | 8.9% / 50% | 3.02% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 51.6% | |
| Operating Margin | -31.7% | |
| Net Margin | -19.6% | |
| Return on Equity (ROE) | -16.8% | |
| Return on Assets (ROA) | -13.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$48M |
| Free Cash Flow | -$76M |
| Total Debt | $76M |
| Debt-to-Equity | 24.8 |
| Current Ratio | 3.8 |
| Total Assets | $642M |
Price & Trading
| Last Close | $46.75 |
| 50-Day MA | $46.31 |
| 200-Day MA | $35.19 |
| Avg Volume | 1.3M |
| Beta | 2.3 |
|
52-Week Range
$23.30
| |
About Twist Bioscience Corp (TWST)
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Purification Calculator
As a halal stock with 3.02% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Twist Bioscience Corp (TWST) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Twist Bioscience Corp is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Twist Bioscience Corp's debt ratio?
Twist Bioscience Corp's debt ratio is 2.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 11.8%.
Does Twist Bioscience Corp require dividend purification?
Yes, Twist Bioscience Corp has an impermissible income ratio of 3.02%, which means 3.02% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Twist Bioscience Corp's key financial metrics?
Twist Bioscience Corp has a market capitalization of $2.7B, and revenue of $377M. The company maintains a gross margin of 51.6% and a net margin of -19.6%. Return on equity stands at -16.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.